Breaking AI & Tech News Analyzed

In a heartfelt video posted on her birthday, the 58‑year‑old vocalist announced that her long‑awaited return to live performance is the best gift she could receive, confirming a series of concerts in Paris slated to begin in September.Diagnosed in December 2022 with stiff‑person syndrome, a rare autoimmune disorder that stiffens muscles and can cause severe pain, Dion was forced to cancel her 2023 Courage world tour. While there is no cure, ongoing treatment has helped stabilize her condition, allowing her to consider a full‑scale comeback.The 2024 documentary “I Am: Céline Dion,” which chronicled her struggle—including a seizure and intense pain—became Amazon’s most‑watched documentary ever. Later that year she made a surprise appearance at the Paris 2024 Olympic Games opening ceremony, delivering Edith Piaf’s “Hymne à l’Amour” to a global audience, marking her first live on‑stage performance since early 2020.Now, Dion will headline ten shows over five weeks at the Paris La Défense Arena, with the residency kicking off on 12 September. She told fans that, despite the challenges, she feels “great, managing my health, feeling good,” and even added that she’s “singing again, even doing a little bit of dancing.”From representing Switzerland at the 1988 Eurovision Song Contest to breaking international charts with 1993’s The Colour of My Love and the iconic 1997 Titanic anthem “My Heart Will Go On,” Dion’s career has spanned decades. Her upcoming Paris run signals not just a personal triumph over illness, but also a major cultural event for fans worldwide.

Harrods has faced criticism over its decision to close a compensation scheme for survivors of alleged sexual abuse by the luxury department store's former owner Mohamed Al Fayed. The scheme was set up in March last year and was due to close on March 31 this year.Kingsley Hayes, partner at KP Law, which is representing nearly 280 survivors, questioned why the scheme was being closed before Harrods had completed an internal investigation into what happened and who knew about it. Hayes stated that the decision appears to be driven by financial considerations rather than what is fair and appropriate for survivors.The scheme provided an alternative resolution for survivors who did not wish to pursue litigation, offering general damages of up to £200,000 and a work impact payment of up to £150,000 as well as payments for 'wrongful testing' and treatment costs. Harrods said more than 220 people had now engaged with the redress scheme, which it said had been designed in consultation with specialist barristers, survivors and their legal representatives.Harrods' decision to close the scheme has been criticized as 'neither fair nor just', with Hayes calling on Harrods to 'do the honourable thing' and delay the closure of the redress scheme and commit to publishing the findings of its long overdue internal investigation into what happened and who knew. Survivors are being asked to make life-altering decisions without access to the full picture.The Metropolitan police said last year that 111 women had made allegations against Fayed; the youngest is thought to have been 13 at the time. Harrods 'apologises unreservedly' for the sexual abuse survivors suffered and 'wants everyone who is eligible to receive this compensation'. A spokesperson for Harrods said the company 'recognises the remarkable bravery of survivors who come forward and continue to shed further light on this dark chapter to our history'.

Dayton Webber, a quadruple amputee cornhole champion, has been arrested on suspicion of murder after allegedly shooting and killing his friend, Bradrick Wells, in a suburban Washington DC area. Webber's ex-girlfriend, Tori Mattingly, claims he had a 'dark side' and was prone to anger and control during their four-year relationship.Mattingly shared a video with TMZ that allegedly shows Webber shouting at her and demanding she leave his property. She also made allegations of abuse and claimed she was not surprised by the murder charge against him.According to the sheriff's office in Charles county, Maryland, Webber was driving three passengers in his car on the night of March 22 when he began arguing with his front-seat passenger, Wells, and shot him twice in the head. Webber allegedly asked his other passengers to help him remove Wells's body from the car, but they refused and fled the vehicle.Police later found Wells's body in a local yard and tracked Webber down about 150 miles away in Virginia, where he had allegedly sought treatment at a hospital for an unspecified medical issue. Webber faces charges of murder, assault, and use of a firearm in the commission of a felony.Despite his disabilities, Webber became a budding wrestler and football player, then became a champion in the sport of cornhole, recording numerous tournament wins in the American Cornhole League (ACL). His former doubles partner, Mike Hoffman, expressed shock and sadness at Webber's arrest, saying 'If the allegations are true, he's made some terrible decisions'.

Liverpool is optimistic that Mohamed Salah will return from injury in the FA Cup quarter-final against Manchester City on Saturday. The Egypt international has been sidelined with a muscle problem sustained during the Champions League match against Galatasaray.Salah, who announced his departure from Liverpool at the end of the season, was also forced to miss Egypt's friendlies against Saudi Arabia and Spain. However, he has responded well to treatment, and there is confidence he will be involved at the Etihad Stadium on Saturday.This potential return comes as Liverpool prepares for a crucial sequence of fixtures that could define their season. Arne Slot's side will be looking to make a strong impression, especially with the Champions League quarter-final first leg against Paris Saint-Germain approaching.In other injury news, Alexander Isak may also be available for the first time since fracturing a leg at Tottenham in December, although his comeback is expected to be more realistic for the Champions League match. The £125m British-record signing is expected to resume team training this week.On the other hand, Alisson, Liverpool's first-choice goalkeeper, is still nursing a hamstring injury and remains a major doubt for the trip to Parc des Princes. The 33-year-old has experienced repeated hamstring injuries in recent seasons.Meanwhile, Florian Wirtz has claimed that he has become a stronger player as a result of the problems he encountered after moving to Liverpool. The Germany international joined for a then club-record £116m from Bayer Leverkusen last summer but has struggled to impose himself in the Premier League.

Eli Lilly, the US pharmaceutical group behind the Mounjaro weight-loss drug, is seeking to resume its investments in the UK after pausing them last year. The company is in talks with UK ministers to regularly increase NHS drug prices and end a rebate scheme. Patrik Jonsson, president of Eli Lilly's international business, expressed optimism about reaching an agreement this summer.The talks will also explore 'innovative' pricing plans, such as linking payments for anti-obesity drugs to whether the treatment helps patients return to work. This comes as the US pharmaceutical industry increases pressure on the UK, with Keir Starmer agreeing to the first increase in NHS cost-effectiveness thresholds in 27 years. The threshold was raised from £20,000 to £30,000 a year for every year of life gained to £25,000 to £35,000.Eli Lilly was one of several pharmaceutical companies that ditched or paused almost £25bn in planned investments in the UK last year. The company paused its plans to invest in a laboratory site in central London. Jonsson stated that the resumption of Eli Lilly's investment would depend on the outcome of its talks with the government.He emphasized that prices for medicines in the UK had been 'far too low for far too long' and that the threshold couldn't remain static for another three decades. The UK agreed to pay 25% more for new medicines by 2035 as part of a US-UK drug pricing deal, which could eventually reach £9bn a year.Large pharmaceutical companies have protested about a 'rebate' scheme, under which they are required to pay back a chunk of revenue from sales of branded medicines. This scheme is expected to fall in 2026, although Jonsson believes payments 'should actually get down to zero' over time.

The UK's retail industry is bracing for the impact of reforms to guaranteed working hours, which could affect over half of retail jobs. The British Retail Consortium (BRC) has warned that the changes, set to take effect from April, may make it harder for shops to employ people, particularly young workers, in part-time roles. The Employment Rights Act will introduce new protections for workers on sick pay, sexual harassment, parental leave, and trade union recognition. Additionally, the act will provide rights to guaranteed hours for those on zero or 'low hours' contracts, flexible working, payment for short-notice cancellation of shifts, and barring fire-and-rehire practices in most circumstances. The BRC, representing major UK retailers, suggests that guaranteed hours protections should only apply to contracts of eight hours a week or fewer, and the reference period to be at least 26 weeks – or ideally a full year. This, they argue, would better reflect seasonal working patterns and ensure reforms address genuine problems without undermining jobs. Helen Dickinson, the chief executive of the BRC, emphasized that flexible retail jobs are vital for millions of people, providing opportunities for students, parents, and those managing health conditions. She warned that if reforms treat flexibility as a problem rather than something workers actively choose, the risk is fewer opportunities and reduced access to work. The BRC noted that 55% of retail roles are part-time, significantly above the UK average of 33%. A survey of 2,000 adults by Opinium for the BRC found that 52% of UK adults think the ability to flex working hours around their lives is important. However, the shop workers' union Usdaw and the TUC have expressed support for the reforms, arguing that they will deliver benefits to those in insecure employment, particularly women and disabled workers, and provide greater job security and predictability for working people.

A groundbreaking analysis has revealed that 37% of conventional California produce contains toxic Pfas pesticide residues. The Environmental Working Group (EWG) conducted the study, which coincided with the introduction of California legislation aimed at banning Pfas from being used as active ingredients in pesticides by 2035.The analysis of California department of pesticide regulation residue testing records found that about 90% of peaches, plums, and nectarines contained Pfas residues, while 80% of strawberries and grapes showed contamination. These findings are particularly alarming as children are most at risk from the toxic effects of Pfas, and commonly eat fruits like grapes and strawberries.Pfas are a class of at least 16,000 compounds used to make products resistant to water, stains, and heat. They are called "forever chemicals" because they do not naturally break down and accumulate, and are linked to cancer, kidney disease, liver problems, immune disorders, birth defects, and other serious health problems.The EWG analyzed records for 930 samples across 78 types of non-organic, California-grown fruits and vegetables. The results showed that 348 samples, or 37%, contained Pfas residues, with at least half of all produce varieties treated with Pfas pesticides.The proposed legislation in California would ban the use of Pfas as an active ingredient in pesticides by 2035 and place a moratorium on approvals of new Pfas pesticides. The bill's author, California assemblymember Nick Schultz, stated that he doesn't want his kids "eating strawberries contaminated with chemicals that will stay in their bodies for decades."The pesticide industry is expected to mount a strong campaign against the legislation, but Maine and Minnesota have already passed similar bans, making it more likely to pass in California.

Tiger Woods, one of the greatest golfers of all time, has once again found himself in the spotlight for all the wrong reasons. His recent arrest on suspicion of driving under the influence (DUI) has raised questions about why golf remains so beholden to him, despite his repeated run-ins with the law and declining performance.In 2010, Woods delivered a 14-minute mea culpa on his transgressions, including his extramarital affairs, in front of a hand-picked audience at the PGA Tour. However, 16 years later, it appears that not much has changed. Woods has continued to struggle with his personal life and has had multiple encounters with the law, including a 2021 car crash in Los Angeles and a 2017 incident where he was found asleep at the wheel of his car.Despite his declining performance, Woods remains a central figure in golf. He is being considered to captain the United States Ryder Cup team and is the chairman of a committee tasked with reshaping the PGA Tour's schedule. However, his behavioral pattern raises questions about the validity of his role in the sport.Woods' actions have consequences not only for himself but also for others. His reckless driving puts not only his own life at risk but also the lives of others on the road. It is unacceptable that an athlete of his standing continues to engage in such behavior and expects to be treated differently than others.The golf community must reassess its relationship with Woods and consider whether his actions align with the values of the sport. While it is possible to feel sympathy for Woods' plight, it is also important to acknowledge that there are consequences for one's actions. The sport must prioritize accountability and responsibility over its dependence on a single individual, no matter how great they may be.

Robert F Kennedy Jr, the US health secretary, has unveiled a chaotic and unpredictable agenda for public health policy under his 'Make America Healthy Again' (Maha) initiative. His approach tends to favor personal choice and autonomy over large-scale, mandatory public health interventions, such as childhood vaccine requirements.The Maha agenda has raised concerns over the potential risks associated with injectable peptide drugs. Mr. Kennedy plans to open up the sale of 'about 14' of these drugs to the public, despite the US Food and Drug Administration (FDA) restricting 17 peptides in 2023 due to 'potential significant safety risks'. None of these peptides have been proven to be safe or effective for human use.The peptides in question are often promoted for biological enhancement, such as increasing muscle mass or cognitive benefits, but the evidence for these effects in humans is thin. Reports of people self-administering peptide therapies, usually bought from China 'for research use only', are widespread, particularly in Silicon Valley.The Maha project wants to make the grey market the only market, effectively sanctioning mass public use of unproven treatments. Peptides are clearly drugs and shouldn’t be allowed for widespread use without rigorous clinical trials. Opening loopholes for sale would undermine the precautionary principle that has successfully led public health policy for generations.It is also worth noting that other governments are unlikely to be as cavalier as Mr. Kennedy about peptides. However, people everywhere will continue to call for more personal choice and more bodily autonomy, and those conversations are important. The case for safety, proof, and regulation must be made to ensure that public health policy prioritizes the well-being of individuals.